Cellosaurus HO-323-3 (CVCL_B6C9)
| Cell line name | HO-323-3 |
|---|---|
| Accession | CVCL_B6C9 |
| Resource Identification Initiative | To cite this cell line use: HO-323-3 (RRID:CVCL_B6C9) |
| Comments | Group: Hybridoma fusion partner cell line. Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Derived from site: In situ; Spleen; UBERON=UBERON_0002106. Cell type: B-cell; CL=CL_0000236. |
| Sequence variations |
|
| Disease | Hereditary spherocytosis (NCIt: C97074) Hereditary spherocytosis (ORDO: Orphanet_822) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_Z045 (HO-323) |
| Sex of cell | Male |
| Age at sampling | 5Y |
| Category | Transformed cell line |
| Publications | PubMed=22359119; DOI=10.1007/BF00145026 PubMed=22359170; DOI=10.1007/BF00365080 PubMed=1368811; DOI=10.1007/BF02525493 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q111733443 |
| Entry history | |
| Entry creation | 17-Mar-2022 |
| Last entry update | 10-Apr-2025 |
| Version number | 6 |